Dr. Aimee Elizabeth Schad, MD

Dr. Schad practices at Advocate Christ Medical Center in Oak Lawn, Illinois, part of Advocate Health.

Dr. Schad's NPI, 1053802975, was assigned on May 25, 2018. Dr. Schad holds Illinois license 036.168819.

Dr. Schad's primary practice is Advocate Christ Medical Center, at 4440 W 95th Street, Oak Lawn, IL 60453 in Cook County. The practice phone is (708) 684-8000.

Dr. Schad's primary practice is Advocate Christ Medical Center in Oak Lawn, Illinois, part of Advocate Health. Dr. Schad is also affiliated with Advocate Trinity Hospital. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Schad to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schad practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Schad's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schad is licensed in Illinois.

CMS data shows 153 Medicare services from Dr. Schad across 5 procedure codes in 2024, for 76 Medicare patients. Medicare paid $10,990 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Schad in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schad's median patient age at 75, with 53% women.

In 2024, Dr. Schad wrote 97 Medicare Part D claims for 39 patients. 86% of them were for generic drugs. CMS names the drug for 38 of them, across 2 drugs with 11 or more claims each, at $295 in total drug cost. In 2021, CMS named 25 claims across 2 drugs.

Dr. Schad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schad as offering telehealth.

Dmand AI links 3 papers to Dr. Schad, published from 2020 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Breast Neoplasms. Dr. Schad's most frequent co-authors are Ruta D. Rao, MD, Jessica Anne Slostad, MD and Jordan D. Berlin, MD.

CMS Open Payments shows 15 general payments to Dr. Schad from 11 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 87% of the total. Adaptive Biotechnologies Corporation paid the most, $177.